Staidson (300204.SZ): SanNuoJiaYi has been recognized as a national high-tech enterprise.

On February 13, Gelonghui reported that Staidson (300204.SZ) announced that its subsidiary, Peking SanNuo JiaYi Biotechnology Co., Ltd. (referred to as "SanNuo JiaYi"), recently received the "High-tech Enterprise Certificate" issued jointly by the Beijing Municipal Science and Technology Commission, Beijing Financial Bureau, and the State Taxation Administration of Beijing Taxation Bureau. SanNuo JiaYi has been recognized as a high-tech enterprise. In 2024, SanNuo JiaYi successfully passed the high-tech enterprise certification and recently obtained the "High-tech Enterprise Certificate," with certificate number GR202411007668, issued on December 3, 2024.

Gelonghui FinanceFeb 13 15:49

Staidson (300204.SZ): The summary report of the Phase IIb clinical study for injectable STSP-0601 has been obtained.

Staidson (300204.SZ) announced that the company has obtained the Phase IIb clinical trial results for the injectable STSP-0601...

Zhitong FinanceJan 20 16:39

Main business income declined, Staidson is expected to report a loss of up to 0.15 billion in 2024 | Interpretations

① Staidson expects revenue in 2024 to decrease by 19.78%-1.95% year-on-year, with a net loss attributable to shareholders of 0.148 billion yuan-0.121 billion yuan, which is a narrowing compared to 2023. ② To integrate resources and reduce costs and increase efficiency, Staidson will deregister three loss-making subsidiaries in 2024.

cls.cnJan 15 23:22

Express News | Staidson: The expected loss for the year 2024 is between 0.121 billion yuan and -0.148 billion yuan.

BreakingsJan 15 16:07

Shu Taishen: 2024 Annual Results Forecast Announcement

SZSIJan 15 16:04 · Announcements

Express News | Staidson: Subsidiary Beijietai's capital increase and Equity Transfer introduce investor Jinyi Yuanli Fund.

BreakingsDec 24, 2024 20:34